• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌药物胡椒碱是口腔鳞状细胞癌中瞬时受体电位 melastatin 7 通道的抑制剂。

Anti-cancer agent piperlongumine is an inhibitor of transient receptor potential melastatin 7 channel in oral squamous cell carcinoma.

机构信息

Department of Stomatology, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Institute of Neuroscience, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Key Laboratory of Neurogenetics and Channelopathies of the Ministry of Education of China, Guangzhou, China.

Department of Prevention and Health-Care, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

出版信息

J Oral Biosci. 2024 Jun;66(2):430-438. doi: 10.1016/j.job.2024.03.002. Epub 2024 Mar 6.

DOI:10.1016/j.job.2024.03.002
PMID:38452870
Abstract

OBJECTIVES

To elucidate the association between the anticancer activities of piperlongumine (PL) and its potential target, transient receptor potential melastatin 7 channel (TRPM7), in oral squamous cell carcinoma (OSCC).

METHODS

The expression levels and electrical characteristics of TRPM7 as well as cell viability in response to various PL treatments were investigated in the OSCC cell line Cal27.

RESULTS

PL treatment resulted in a concentration- and time-dependent reduction in TRPM7 mRNA and protein expression in Cal27 cells. Furthermore, PL treatment inhibited TRPM7-like rectifying currents in Cal27 cells; however, this inhibition was less effective than that of the TRPM7 antagonist waixenicin A. Rapid perfusion and washout experiments revealed an immediate inhibitory effect of PL on TRPM7-like currents. The antagonistic effect of PL occurred within 1 min and was not completely reversed following washout. Notably, the extracellular Ca concentration still influenced PL-induced changes in the TRPM7-like current, indicating that PL can directly but gently antagonize the TRPM7 channel. Functional changes in TRPM7 correlated with the observed antiproliferative and cytotoxic effects of PL in Cal27 cells.

CONCLUSIONS

These findings suggest that PL exhibits potent inhibitory effects on TRPM7 and exerts its anti-cancer effects by downregulating TRPM7 expression and antagonizing channel currents.

摘要

目的

阐明胡椒碱(PL)的抗癌活性与其潜在靶标瞬时受体电位 melastatin 7 通道(TRPM7)在口腔鳞状细胞癌(OSCC)中的关联。

方法

在 OSCC 细胞系 Cal27 中研究了 TRPM7 的表达水平和电特性以及对各种 PL 处理的细胞活力。

结果

PL 处理导致 Cal27 细胞中 TRPM7 mRNA 和蛋白表达呈浓度和时间依赖性降低。此外,PL 处理抑制了 Cal27 细胞中的 TRPM7 样整流电流;然而,这种抑制作用不如 TRPM7 拮抗剂 Waixenicin A 有效。快速灌注和冲洗实验显示 PL 对 TRPM7 样电流具有即刻抑制作用。PL 的拮抗作用在 1 分钟内发生,冲洗后并未完全逆转。值得注意的是,细胞外 Ca 浓度仍影响 PL 诱导的 TRPM7 样电流变化,表明 PL 可直接但温和地拮抗 TRPM7 通道。TRPM7 的功能变化与在 Cal27 细胞中观察到的 PL 抗增殖和细胞毒性作用相关。

结论

这些发现表明,PL 对 TRPM7 具有强大的抑制作用,并通过下调 TRPM7 表达和拮抗通道电流发挥其抗癌作用。

相似文献

1
Anti-cancer agent piperlongumine is an inhibitor of transient receptor potential melastatin 7 channel in oral squamous cell carcinoma.抗癌药物胡椒碱是口腔鳞状细胞癌中瞬时受体电位 melastatin 7 通道的抑制剂。
J Oral Biosci. 2024 Jun;66(2):430-438. doi: 10.1016/j.job.2024.03.002. Epub 2024 Mar 6.
2
[Expression of LINC 00478 in oral squamous cell carcinoma and its effect on proliferation, migration and invasion].[LINC 00478在口腔鳞状细胞癌中的表达及其对增殖、迁移和侵袭的影响]
Shanghai Kou Qiang Yi Xue. 2025 Apr;34(2):126-131.
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity.Src家族激酶抑制剂药物达沙替尼与糖皮质激素对舌鳞状细胞癌具有协同活性,并降低MET激酶活性。
Cell Commun Signal. 2025 Jun 19;23(1):293. doi: 10.1186/s12964-025-02129-8.
5
assessment of BBI608 in 2D and 3D culture models for drug repositioning in oral squamous cell carcinoma.在二维和三维培养模型中评估BBI608用于口腔鳞状细胞癌的药物重新定位
Oncol Rep. 2025 Aug;54(2). doi: 10.3892/or.2025.8930. Epub 2025 Jun 20.
6
Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.二氢青蒿素通过下调线粒体钙单向转运蛋白抑制口腔鳞状细胞癌的进展。
Bioengineered. 2022 Jan;13(1):227-241. doi: 10.1080/21655979.2021.2012951.
7
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
8
Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway.通过抑制 Hippo-YAP 信号通路,负载胡椒碱的智能纳米粒逆转口腔鳞状细胞癌的顺铂耐药性。
Transl Res. 2024 Jun;268:63-78. doi: 10.1016/j.trsl.2024.03.004. Epub 2024 Mar 16.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.